Bank of New York Mellon Corp - GEMINI THERAPEUTICS INC ownership

GEMINI THERAPEUTICS INC's ticker is GMTX and the CUSIP is 36870G105. A total of 2 filers reported holding GEMINI THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of GEMINI THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$18,000
-5.3%
11,0080.0%0.00%
Q2 2022$19,000
-80.2%
11,008
-84.1%
0.00%
Q1 2022$96,000
-53.2%
69,078
-2.3%
0.00%
Q4 2021$205,000
-30.5%
70,737
-3.2%
0.00%
Q3 2021$295,000
-27.0%
73,059
+16.8%
0.00%
Q2 2021$404,000
+155.7%
62,555
+436.9%
0.00%
Q1 2021$158,00011,6510.00%
Other shareholders

There were no reported owners of GEMINI THERAPEUTICS INC in Q4 2022.

NameSharesValueWeighting ↓
View complete list of GEMINI THERAPEUTICS INC shareholders